BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34887369)

  • 21. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric Lymphoma.
    Etchebehere E; Andrade R; Camacho M; Lima M; Brink A; Cerci J; Nadel H; Bal C; Rangarajan V; Pfluger T; Kagna O; Alonso O; Begum FK; Mir KB; Magboo VP; Menezes LJ; Paez D; Pascual TN
    J Nucl Med Technol; 2022 Sep; 50(3):256-262. PubMed ID: 35440476
    [No Abstract]   [Full Text] [Related]  

  • 23. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
    Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
    BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.
    Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H
    Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of 18F-FDG PET/CT-Metabolic Parameters at Baseline and Interim Assessment in Pediatric Anaplastic Large Cell Lymphoma.
    Mathew B; Vijayasekharan K; Shah S; Purandare NC; Agrawal A; Puranik A; Prasad M; Narula G; Banavali S; Rangarajan V
    Clin Nucl Med; 2020 Mar; 45(3):182-186. PubMed ID: 31977486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Value of Combining
    Sookha RR; Zhi W; Shen Y; Lazare C; Wang L; Meng Y; Cao C; Hu J; Wu P
    J Cancer; 2018; 9(17):3101-3108. PubMed ID: 30210633
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma.
    Otani T; Miyake KK; Ishimori T; Kido A; Saga T; Nakamoto Y
    Asia Ocean J Nucl Med Biol; 2023; 11(2):101-110. PubMed ID: 37324226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Recurrent Cervical Cancer and Prediction of Its Patient Survival with Serum Squamous-Cell Carcinoma-Antigen and 2-[
    Peng NJ; Hu C; Chiu YL; Yu CC; Li CJ; Sheu JJ; Chiang AJ
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32878219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of circulating tumor cells and whole-body metabolic tumor volume of
    Fu L; Zhu Y; Jing W; Guo D; Kong L; Yu J
    Chin J Cancer Res; 2018 Dec; 30(6):596-604. PubMed ID: 30700928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R
    Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
    Aydos U; Tahtaci G; Özgür Akdemir Ü; Özet A
    Nucl Med Commun; 2020 Nov; 41(11):1199-1209. PubMed ID: 32796455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
    Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y
    Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour
    Bae MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3341-3348. PubMed ID: 32642973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.
    Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG-PET/CT in laryngeal cancer: comparison with conventional imaging and prognostic role.
    Albano D; Dondi F; Paderno A; Nocivelli G; Maddalo M; Magrini SM; Nicolai P; Maroldi R; Giubbini R; Bertagna F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(4):229-238. PubMed ID: 34218885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma.
    Fonti R; Pellegrino S; Catalano L; Pane F; Del Vecchio S; Pace L
    Ann Hematol; 2020 Jan; 99(1):127-135. PubMed ID: 31776725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.